Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation

Nature Chemical Biology

Volumn 9, Issue 12, 2013, Pages 796-804

  Zlitni, Soumaya ^a   Ferruccio, Lauren F ^a   Brown, Eric D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; GLYCINE;

AMINO ACID METABOLISM; ARTICLE; BACTERIAL METABOLISM; BIOSYNTHESIS; CONTROLLED STUDY; ESCHERICHIA COLI; GROWTH INHIBITION; METABOLIC REGULATION; METABOLITE; MOLECULAR INTERACTION; NONHUMAN; NUTRIENT LIMITATION; PRIORITY JOURNAL; TIME;

ANTI-BACTERIAL AGENTS; CLONING, MOLECULAR; CULTURE MEDIA; ESCHERICHIA COLI K12; ESCHERICHIA COLI PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; RECOMBINANT PROTEINS; TRANSCRIPTOME;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84888004411     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1361     Document Type: Article

References (58)

1. Brown, E.D. Is the GAIN Act a turning point in new antibiotic discovery? Can. J. Microbiol. 59, 153-156 (2013).
2. Haselbeck, R. et al. Comprehensive essential gene identification as a platform for novel anti-infective drug discovery. Curr. Pharm. Des. 8, 1155-1172 (2002).
3. Boucher, H. et al. 10 × ′20 Progress-development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin. Infect. Dis. 56, 1685-1694 (2013).
4. Payne, D.J., Gwynn, M.N., Holmes, D.J. & Pompliano, D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29-40 (2007).
5. Burdine, L. & Kodadek, T. Target identification in chemical genetics: the (often) missing link. Chem. Biol. 11, 593-597 (2004).
6. Parsons, A.B. et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22, 62-69 (2004).
7. Giaever, G. et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA 101, 793-798 (2004).
8. Hoon, S. et al. An integrated platform of genomic assays reveals small-molecule bioactivities. Nat. Chem. Biol. 4, 498-506 (2008)
9. erratum 4, 632 (2008).
10. Lum, P.Y. et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116, 121-137 (2004).
11. Li, X. et al. Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chem. Biol. 11, 1423-1430 (2004).
12. Pathania, R. et al. Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting. Nat. Chem. Biol. 5, 849-856 (2009).
13. Hua, Q., Yang, C., Oshima, T., Mori, H. & Shimizu, K. Analysis of gene expression in Escherichia coli in response to changes of growth-limiting nutrient in chemostat cultures. Appl. Environ. Microbiol. 70, 2354-2366 (2004).
14. Tao, H., Bausch, C., Richmond, C., Blattner, F.R. & Conway, T. Functional genomics: expression analysis of Escherichia coli growing on minimal and rich media. J. Bacteriol. 181, 6425-6440 (1999).
15. Zaslaver, A. et al. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat. Methods 3, 623-628 (2006).
16. Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 2006.0008 (2006).
17. Chamberlain, L.M., Strugnell, R., Dougan, G., Hormaeche, C.E. & Demarco de Hormaeche, R. Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic. Microb. Pathog. 15, 51-63 (1993).
18. Cuccui, J. et al. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect. Immun. 75, 1186-1195 (2007).
19. Mei, J.M., Nourbakhsh, F., Ford, C. & Holden, D. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol. Microbiol. 26, 399-407 (1997).
20. Polissi, A. et al. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 66, 5620-5629 (1998).
21. Samant, S. et al. Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog. 4, e37 (2008).
22. Cersini, A., Salvia, A.M. & Bernardini, M.L. Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect. Immun. 66, 549-557 (1998).
23. Ho, J.M. & Juurlink, D. Considerations when prescribing trimethoprim-sulfamethoxazole. CMAJ 183, 1851-1858 (2011).
24. Pittard, J. & Yang, J. in Escherichia coli and Salmonella: Cellular and Molecular Biology (eds. Böck, A. et al.) (ASM Press, Washington, D.C., 2008).
25. Zhang, J.H., Chung, T.D. & Oldenburg, K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67-73 (1999).
26. Longley, D.B., Harkin, D.P. & Johnston, P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3, 330-338 (2003).
27. Handschumacher, R.E. Orotidylic acid decarboxylase: inhibition studies with azauridine 5′-phosphate. J. Biol. Chem. 235, 2917-2919 (1960).
28. Cobb, J.R., Pearcy, S. & Gholson, R. Metabolism of 6-aminonicotinic acid in Escherichia coli. J. Bacteriol. 131, 789-794 (1977).
29. Richmond, M.H. The effect of amino acid analogues on growth and protein synthesis in microorganisms. Bacteriol. Rev. 26, 398-420 (1962).
30. Eidinoff, M.L., Knoll, J.E., Marano, B. & Cheong, L. Pyrimidine studies I. Effect of DON (6-diazo-5-oxo-l-norleucine) on incorporation of precursors into nucleic acid pyrimidines. Cancer Res. 18, 105-109 (1958).
31. Levenberg, B., Melnick, I. & Buchanan, J. Biosynthesis of the purines. XV. The effect of aza-l-serine and 6-diazo-5-oxo-l-norleucine on inosinic acid biosynthesis de novo. J. Biol. Chem. 225, 163-176 (1957).
32. Ahluwalia, G.S., Grem, J., Hao, Z. & Cooney, D. Metabolism and action of amino acid analog anti-cancer agents. Pharmacol. Ther. 46, 243-271 (1990).
33. Wargel, R.J., Shadur, C.A. & Neuhaus, F.C. Mechanism of d-cycloserine action: transport systems for d-alanine, d-cycloserine, l-alanine, and glycine. J. Bacteriol. 103, 778-788 (1970).
34. Zawadzke, L.E., Bugg, T.D. & Walsh, C.T. Existence of two d-alanine:d-alanine ligases in Escherichia coli: cloning and sequencing of the ddlA gene and purification and characterization of the DdlA and DdlB enzymes. Biochemistry 30, 1673-1682 (1991).
35. Neuhaus, F.C. & Lynch, J.L. The enzymatic synthesis of d-alanyl-d-alanine. 3. on the inhibition of d-alanyl-d-alanine synthetase by the antibiotic d-cycloserine. Biochemistry 3, 471-480 (1964).
36. Strominger, J.L., Ito, E. & Threnn, R.H. Competitive inhibition of enzymatic reactions by oxamycin. J. Am. Chem. Soc. 82, 998-999 (1960).
37. Stokstad, E.L. & Jukes, T.H. Sulfonamides and folic acid antagonists: a historical review. J. Nutr. 117, 1335-1341 (1987).
38. Green, J.M., Nichols, B.P. & Matthews, R.G. in Escherichia coli and Salmonella: Cellular and Molecular Biology (eds. Neidhardt, F.C. et al.) 665-673 (ASM Press, Washington, D.C., 1996).
39. Walsh, C. Antibiotics: Actions, Origins, Resistance (ASM Press, Washington, D.C., 2003).
40. Fischer, R.S., Berry, A., Gaines, C.G. & Jensen, R.A. Comparative action of glyphosate as a trigger of energy drain in eubacteria. J. Bacteriol. 168, 1147-1154 (1986).
41. Stauffer, G.V. in Escherichia coli and Salmonella: Cellular and Molecular Biology (eds. Böck, A. et al.) (ASM Press, Washington, D.C., 2004).
42. Morris, J.G. Utilization of l-threnonine by a pseudomonad: a catabolic role for l-threonine aldolase. Biochem. J. 115, 603-605 (1969).
43. Morrison, J.F. & Walsh, C.T. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. 61, 201-301 (1988).
44. Copeland, R.A. Enzymes: a Practical Introduction to Structure, Mechanism, and Data Analysis (Wiley, New York, 2004).
45. Cronan, J.E. in Escherichia coli and Salmonella: Cellular and Molecular Biology (eds. Böck, A. et al.) (ASM Press, Washington, D.C., 2008).
46. Lin, S., Hanson, R.E. & Cronan, J.E. Biotin synthesis begins by hijacking the fatty acid synthetic pathway. Nat. Chem. Biol. 6, 682-688 (2010).
47. Stoner, G.L. & Eisenberg, M.A. Biosynthesis of 7,8-diaminopelargonic acid from 7-keto-8-aminopelargonic acid and S-adenosyl-l-methionine. The kinetics of the reaction. J. Biol. Chem. 250, 4037-4043 (1975).
48. Shapiro, S. Speculative strategies for new antibacterials: all roads should not lead to Rome. J. Antibiot. (Tokyo) 66, 371-386 (2013).
49. Schneider, G. & Lindqvist, Y. Structural enzymology of biotin biosynthesis. FEBS Lett. 495, 7-11 (2001).
50. Woong Park, S. et al. Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression. PLoS Pathog. 7, e1002264 (2011).
51. Lightcap, E.S. & Silverman, R. Slow-binding inhibition of ?-aminobutyric acid aminotransferase by hydrazine analogues. J. Med. Chem. 39, 686-694 (1996).
52. Sambrook, J. & Russell, D.W. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, New York, 2001).
53. Sneath, P.H.A. & Sokal, R.R. Numerical Taxonomy: The Principles and Practice of Numerical Classification (W. H. Freeman, San Francisco, 1973).
54. Romesburg, C. Cluster Analysis For Researchers (Lulu Press, Morrisville, N.C., 2004).
55. Baba, T. & Mori, H. The construction of systematic in-frame, single-gene knockout mutant collection in Escherichia coli K-12. Methods Mol. Biol. 416, 171-181 (2008).
56. Walsh, C.T., Erion, M., Walts, A., Delany, J. & Berchtold, G. Chorismate aminations: partial purification of Escherichia coli PABA synthase and mechanistic comparison with anthranilate synthase. Biochemistry 26, 4734-4745 (1987).
57. Genghof, D.S., Partridge, C.W. & Carpenter, F.H. An agar plate assay for biotin. Arch. Biochem. 17, 413-420 (1948).
58. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682 (2012).